Actelion Current Ratio 2006-2017 | ALIOF

Current and historical current ratio for Actelion (ALIOF) from 2006 to 2017. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Actelion current ratio for the three months ending March 31, 2017 was 2.76.
Actelion Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2017-03-31 $1.44B $0.52B 2.76
2016-12-31 $1.21B $0.58B 2.10
2016-09-30 $1.11B $0.52B 2.15
2016-06-30 $1.08B $0.48B 2.25
2016-03-31 $1.10B $0.43B 2.56
2015-12-31 $1.00B $0.44B 2.29
2015-09-30 $1.25B $0.66B 1.90
2015-06-30 $1.28B $0.71B 1.80
2015-03-31 $1.79B $0.65B 2.74
2014-12-31 $1.89B $0.73B 2.60
2014-09-30 $1.79B $0.45B 3.95
2014-06-30 $1.66B $0.42B 3.92
2014-03-31 $1.66B $0.49B 3.39
2013-12-31 $2.18B $1.05B 2.08
2013-09-30 $2.09B $1.04B 2.00
2013-06-30 $2.15B $1.03B 2.07
2013-03-31 $1.64B $0.52B 3.13
2012-12-31 $1.74B $0.49B 3.55
2012-09-30 $1.78B $0.52B 3.45
2012-06-30 $1.70B $0.47B 3.59
2012-03-31 $1.69B $0.46B 3.65
2011-12-31 $2.24B $0.60B 3.76
2011-09-30 $2.64B $1.15B 2.31
2011-06-30 $2.36B $1.00B 2.35
2011-03-31 $2.23B $0.99B 2.25
2010-12-31 $2.03B $0.96B 2.12
2010-09-30 $1.98B $0.88B 2.26
2010-06-30 $1.74B $0.79B 2.20
2010-03-31 $1.70B $0.83B 2.05
2009-12-31 $0.00B 0.00
2009-09-30 $0.00B 0.00
2009-06-30 $0.00B 0.00
2009-03-31 $1.40B $0.69B 2.03
2008-12-31 $1.38B $0.85B 1.62
2008-09-30 $1.36B $0.80B 1.70
2008-06-30 $1.14B $0.77B 1.49
2008-03-31 $1.09B $0.71B 1.53
2007-12-31 $1.06B $0.68B 1.55
2007-09-30 $0.95B $0.62B 1.54
2007-06-30 $0.94B $0.60B 1.58
2007-03-31 $0.86B $0.57B 1.51
2006-12-31 $1.14B $0.68B 1.67
2006-09-30 $0.73B $0.17B 4.26
2006-06-30 $0.56B $0.13B 4.16
2006-03-31 $0.49B $0.13B 3.85
2005-12-31 $0.48B $0.14B 3.40
2005-09-30 $0.43B $0.12B 3.64
2005-06-30 $0.39B $0.10B 3.76
2005-03-31 $0.38B $0.10B 3.82
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $29.891B $2.455B
Actelion Limited is an independent, profitable, biopharmaceutical company discovering, developing and marketing drugs for high unmet medical needs.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.966B 13.32
Gilead Sciences (GILD) United States $83.231B 10.22
CSL (CSLLY) Australia $72.709B 0.00
Celgene (CELG) United States $69.932B 10.82
Vertex Pharmaceuticals (VRTX) United States $44.858B 48.48
Illumina (ILMN) United States $44.542B 52.33
Biogen (BIIB) United States $43.376B 7.71
Regeneron Pharmaceuticals (REGN) United States $31.308B 14.21
Alexion Pharmaceuticals (ALXN) United States $23.091B 12.17
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $16.891B 49.71
Exact Sciences (EXAS) United States $13.653B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.549B 0.00
Genmab (GNMSF) Denmark $12.505B 70.14
Seattle Genetics (SGEN) United States $11.778B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.952B 53.35
Alnylam Pharmaceuticals (ALNY) United States $9.507B 0.00
Galapagos (GLPG) Belgium $8.668B 0.00
QIAGEN (QGEN) Netherlands $7.676B 25.22
Bio-Techne Corp (TECH) United States $7.518B 51.94
Guardant Health (GH) United States $6.852B 0.00
Sarepta Therapeutics (SRPT) United States $6.220B 0.00
BeiGene (BGNE) Cayman Islands $6.215B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.092B 0.00
Amarin (AMRN) Ireland $6.048B 0.00
Bluebird Bio (BLUE) United States $5.938B 0.00
Moderna (MRNA) United States $5.871B 0.00
Exelixis (EXEL) United States $5.837B 15.17
Horizon Pharma Public (HZNP) Ireland $4.924B 12.52
ARGENX SE-ADR (ARGX) Netherlands $4.890B 0.00
Ascendis Pharma (ASND) Denmark $4.355B 0.00
Repligen (RGEN) United States $4.228B 82.04
China Biologic Products (CBPO) China $4.060B 25.34
Spark Therapeutics (ONCE) United States $4.007B 0.00
Blueprint Medicines (BPMC) United States $3.904B 0.00
Medicines (MDCO) United States $3.756B 0.00
MorphoSys AG (MOR) Germany $3.690B 0.00
Mirati Therapeutics (MRTX) United States $3.606B 0.00
Alkermes (ALKS) Ireland $3.375B 0.00
Immunomedics (IMMU) United States $3.246B 0.00
Emergent Biosolutions (EBS) United States $2.749B 41.29
Reata Pharmaceuticals (RETA) United States $2.714B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.700B 0.00
Genomic Health (GHDX) United States $2.652B 49.73
Arena Pharmaceuticals (ARNA) United States $2.605B 5.60
MyoKardia (MYOK) United States $2.566B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.512B 0.00
Amicus Therapeutics (FOLD) United States $2.434B 0.00
Halozyme Therapeutics (HALO) United States $2.402B 0.00
Acceleron Pharma (XLRN) United States $2.279B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.264B 0.00
NeoGenomics (NEO) United States $2.255B 120.61
Myriad Genetics (MYGN) United States $2.053B 21.55
Akcea Therapeutics (AKCA) United States $2.041B 0.00
Cambrex (CBM) United States $2.007B 25.37
Zai Lab (ZLAB) China $1.998B 0.00
Ligand Pharmaceuticals (LGND) United States $1.887B 23.86
Denali Therapeutics (DNLI) United States $1.763B 0.00
UniQure (QURE) Netherlands $1.737B 0.00
Insmed (INSM) United States $1.730B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.658B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.565B 0.00
Coherus BioSciences (CHRS) United States $1.435B 0.00
REGENXBIO (RGNX) United States $1.421B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.399B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.335B 0.00
Alector (ALEC) United States $1.324B 0.00
Editas Medicine (EDIT) United States $1.252B 0.00
Sangamo Therapeutics (SGMO) United States $1.246B 0.00
RA PHARMCTL INC (RARX) United States $1.212B 0.00
AnaptysBio (ANAB) United States $1.154B 0.00
Fate Therapeutics (FATE) United States $1.151B 0.00
Innoviva (INVA) United States $1.126B 3.25
Athenex (ATNX) United States $1.093B 0.00
Epizyme (EPZM) United States $1.069B 0.00
Zymeworks (ZYME) Canada $1.014B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.980B 0.00
Twist Bioscience (TWST) United States $0.971B 0.00
Cara Therapeutics (CARA) United States $0.929B 0.00
ANI Pharmaceuticals (ANIP) United States $0.884B 14.77
WAVE Life Sciences (WVE) Singapore $0.879B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.875B 0.00
Codexis (CDXS) United States $0.860B 0.00
Principia Biopharma (PRNB) United States $0.838B 436.88
Arvinas (ARVN) United States $0.820B 0.00
Pharming Group (PHGUF) Netherlands $0.793B 0.00
Zealand Pharma (ZEAL) Denmark $0.766B 8.88
Cytokineticsorporated (CYTK) United States $0.766B 0.00
UROGEN PHARMA (URGN) United States $0.757B 0.00
Anika Therapeutics (ANIK) United States $0.749B 26.50
ZIOPHARM Oncology Inc (ZIOP) United States $0.744B 0.00
Intellia Therapeutics (NTLA) United States $0.727B 0.00
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Vericel (VCEL) United States $0.712B 0.00
Mesoblast (MESO) Australia $0.708B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.703B 25.36
Revance Therapeutics (RVNC) United States $0.617B 0.00
MiMedx (MDXG) United States $0.584B 0.00
DBV Technologies S.A (DBVT) France $0.579B 0.00
Heska (HSKA) United States $0.546B 70.74
Achillion Pharmaceuticals (ACHN) United States $0.532B 0.00
Retrophin (RTRX) United States $0.530B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Cellectis S.A (CLLS) France $0.521B 0.00
Stemline Therapeutics (STML) United States $0.508B 0.00
Intra-Cellular Therapies (ITCI) United States $0.504B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.502B 0.00
Precision BioSciences (DTIL) United States $0.494B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
Syros Pharmaceuticals (SYRS) United States $0.466B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.440B 0.00
Puma Biotechnology (PBYI) United States $0.435B 0.00
BioDelivery Sciences (BDSI) United States $0.429B 0.00
Arcus Biosciences (RCUS) United States $0.424B 0.00
CytomX Therapeutics (CTMX) United States $0.421B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.409B 0.00
Agenus (AGEN) United States $0.408B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.404B 0.00
Adverum Biotechnologies (ADVM) United States $0.399B 0.00
Merus (MRUS) Netherlands $0.398B 0.00
Bellus Health (BLU) Canada $0.391B 0.00
Protagonist Therapeutics (PTGX) United States $0.364B 0.00
AC Immune SA (ACIU) Switzerland $0.351B 26.00
Gritstone Oncology (GRTS) United States $0.350B 0.00
Kadmon Holdings (KDMN) United States $0.344B 0.00
Prothena (PRTA) Ireland $0.342B 0.00
Scholar Rock Holding (SRRK) United States $0.330B 0.00
Theratechnologies (THERF) Canada $0.327B 0.00
Avid Bioservices (CDMO) United States $0.326B 0.00
Albireo Pharma (ALBO) United States $0.316B 0.00
ADMA Biologics Inc (ADMA) United States $0.314B 0.00
Biofrontera AG (BFRA) Germany $0.312B 466.67
Kindred Biosciences (KIN) United States $0.309B 0.00
Sorrento Therapeutics (SRNE) United States $0.309B 0.00
Pfenex (PFNX) United States $0.307B 0.00
Cel-Sci (CVM) United States $0.301B 0.00
Starpharma Holdings (SPHRY) Australia $0.295B 0.00
Dynavax Technologies (DVAX) United States $0.289B 0.00
Cellular Biomedicine (CBMG) United States $0.288B 0.00
Clovis Oncology (CLVS) United States $0.281B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.276B 0.00
Geron (GERN) United States $0.271B 0.00
Seres Therapeutics (MCRB) United States $0.267B 0.00
Senesco Technologies (ELOX) United States $0.259B 0.00
MannKind (MNKD) United States $0.254B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.250B 0.00
ChromaDex (CDXC) United States $0.250B 0.00
Sutro Biopharma (STRO) United States $0.249B 0.00
PDL BioPharma (PDLI) United States $0.249B 6.41
Inovio Pharmaceuticals (INO) United States $0.249B 0.00
Prometic Life Sciences (PFSCF) Canada $0.242B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.240B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.238B 0.00
Affimed (AFMD) Germany $0.228B 0.00
POXEL SA FRANCE (PXXLF) France $0.228B 0.00
Athersys (ATHX) United States $0.224B 0.00
Spero Therapeutics (SPRO) United States $0.224B 0.00
Compugen (CGEN) Israel $0.220B 0.00
EXICURE INC (XCUR) United States $0.217B 0.00
Palatin Technologies (PTN) United States $0.215B 6.32
Bicycle Therapeutics (BCYC) United Kingdom $0.213B 0.00
Kamada (KMDA) Israel $0.207B 7.92
CorMedix Inc (CRMD) United States $0.203B 0.00
Cue Biopharma (CUE) United States $0.199B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.197B 0.00
Five Prime Therapeutics (FPRX) United States $0.196B 0.00
XOMA (XOMA) United States $0.188B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.183B 0.00
Arsanis (XFOR) United States $0.175B 0.00
Nicox SA (NICXF) France $0.173B 0.00
Acorda Therapeutics (ACOR) United States $0.171B 0.00
Enzo Biochem (ENZ) United States $0.168B 0.00
Alcobra (ARCT) United States $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Dyadic (DYAI) United States $0.164B 0.00
Novavax (NVAX) United States $0.161B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.159B 0.00
Abeona Therapeutics (ABEO) United States $0.158B 0.00
Strongbridge Biopharma (SBBP) United States $0.150B 6.16
BioTime (LCTX) United States $0.150B 10.00
Northwest Biotherapeutics (NWBO) United States $0.145B 0.00
Cerecor (CERC) United States $0.143B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.143B 0.00
PHASEBIO PHARMA (PHAS) United States $0.142B 0.00
Adocia (ADOCY) France $0.140B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.135B 0.00
Aptinyx (APTX) United States $0.134B 0.00
NantKwest (NK) United States $0.134B 0.00
Emmaus Life Sciences (EMMA) United States $0.133B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Fortress Biotech (FBIO) United States $0.125B 0.00
Menlo Therapeutics (MNLO) United States $0.122B 0.00
SESEN BIO, INC (SESN) United States $0.111B 0.00
Celyad SA (CYAD) Belgium $0.101B 0.00
Aduro Biotech (ADRO) United States $0.100B 0.00
Verastem (VSTM) United States $0.096B 0.00
OvaScience (MLND) United States $0.094B 0.00
VTv Therapeutics (VTVT) United States $0.093B 0.00
Trevena (TRVN) United States $0.093B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.092B 0.00
Arbutus Biopharma (ABUS) Canada $0.091B 0.00
Vaccinex (VCNX) United States $0.090B 0.00
Checkpoint Therapeutics (CKPT) United States $0.090B 0.00
Mersana Therapeutics (MRSN) United States $0.087B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.086B 0.00
Idera Pharmaceuticals (IDRA) United States $0.084B 0.00
Selecta Biosciences (SELB) United States $0.080B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.078B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.076B 0.00
NewLink Genetics (NLNK) United States $0.073B 0.00
Catalyst Biosciences (CBIO) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
Curis (CRIS) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 38.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Orgenesis (ORGS) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.067B 0.00
Pluristem Therapeutics (PSTI) Israel $0.067B 0.00
VBI Vaccines (VBIV) United States $0.066B 0.00
AquaBounty Technologies (AQB) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.062B 0.00
Unum Therapeutics (UMRX) United States $0.061B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.059B 0.00
Prima BioMed (IMMP) Australia $0.057B 0.00
AIT Therapeutics (XAIR) United States $0.050B 0.00
VistaGen Therapeutics (VTGN) United States $0.050B 0.00
Proteostasis Therapeutics (PTI) United States $0.048B 0.00
Stellar Biotechnologies (EDSA) Canada $0.046B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
Oncobiologics (OTLK) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
VIVUS (VVUS) United States $0.045B 0.00
Evogene (EVGN) Israel $0.042B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
BIOCARDIA INC (BCDA) United States $0.039B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.033B 0.00
Protalix BioTherapeutics (PLX) Israel $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.028B 9.73
Apricus Biosciences (SEEL) United States $0.027B 0.00
Clearside Biomedical (CLSD) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
TOCAGEN INC (TOCA) United States $0.020B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
IBio (IBIO) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00